HYDERABAD: Bharat Biotech, which has just received Emergency Use Authorisation (EUA) from the Indian drug regulators for Covaxin, is all geared up to begin supplies with a stockpile of 20 million doses in place and plans to scale up. This was stated by Bharat Biotech chairman and managing director Dr Krishna Ella on Monday.
“We have 20 million doses stockpiled now but we are aiming to get to 700 million doses capacity in four facilities, three facilities in Hyderabad and one in Bangalore,” he said. He also pointed out that the company expects to have more than 150 million doses of Covaxin ready by July-August 2021. On preparedness to rollout the vaccine, Ella said that batches of the vaccine have been already sent to Central Research Institute (CRI) Kasauli.